Dyax Corp. (Nasdaq: DYAX) announced that it has received guidance in a recent meeting with the U.S. Food and Drug ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE